Introduction
Nocardia farcinica infection has been increasingly diagnosed because of the growing population of immunocompromised hosts and the use of improved methods for detection and identification of Nocardia species in the clinical laboratory. N. farcinica can cause a variety of clinical presentations including localized diseases and disseminated infections, especially in immunocompromised patients (Brown & McNeil, 2003; Boiron et al., 1992; Torres et al., 2000) . In this report, we describe a disseminated infection (bacteraemia, multilobar pneumonia and brain abscesses) caused by N. farcinica that occurred in a patient with end-stage renal disease, and review the reported cases of N. farcinica bacteraemia in the English literature.
Case report
This 68-year-old man had chronic glomerulonephritisrelated end-stage renal disease and had received regular haemodialysis for 3 years. His past medical history included splenectomy due to idiopathic thrombocytopenia purpura (ITP) 6 years before this admission, an episode of nontyphoidal salmonellosis with a mycotic abdominal aneurysm 3 years before and excision of colon cancer 7 months before. He had taken prednisolone (10 mg twice daily) orally for ITP for 2 months prior to this admission. He presented at our hospital complaining of fever, chills, headache and productive cough for 7 days. He reported having visited a farm about 2 weeks prior to admission. He did not recall any recent insect bites, injuries or wounds of the trunk or extremities. On physical examination, he was lethargic with clear consciousness. Vital signs included a temperature of 39 8C, blood pressure of 160/80 mmHg, a pulse rate of 90 min À1 and regular respiration of 20 min À1 . There was no meningeal or focal neurological sign. The breathing sounds were clear and no neck lymphadenopathy was found. The skin of the four limbs was intact, except for the clean puncture wound of the arterio-venous shunt over the left forearm. . Chest x-ray and computed tomography showed multilobar nodular lesions with central necrosis (Fig. 1A) .
Treatment with intravenous ampicillin/sulbactam (1 . 5 g day À1 ) was initiated. One day after admission, a sputum smear was positive for Gram-positive, branching, filamentous rods, which were acid-fast by the modified Kinyoun method (Fig. 1B) . Magnetic resonance imaging of the brain revealed two hypodense lesions with ring enhancement (one 4 . 2 mm 3 4 . 6 mm nodule at the left parietal lobe and another 3 . 6 mm 3 3 . 2 mm nodule at the right temporal lobe), indicating the presence of brain abscesses. Intravenous trimethoprim/sulfamethoxazole (160 mg/800 mg Abbreviation: ITP, idiopathic thrombocytopenia purpura.
day
À1 ) was administered for the treatment of suspected disseminated Nocardia infection. Rapid resolution of the respiratory signs and symptoms was noted, with subsidence of fever. On the fourth day in hospital, cultures of the sputum sample and two sets of blood cultures collected on the first day all yielded a Rhodococcus or Nocardia species based on identification by the API CORYNE system (identification profile 3151004) (bioMérieux). Meropenem (500 mg every 2 days) was added to the antimicrobial regimen to cover the possibility of rhodococcal infection. The general condition of the patient continued to improve with this combination therapy.
The isolates were Gram-positive, branching, partially acidfast bacilli. They were aesculin-positive, tyrosine-negative, arylsulfatase-negative and grew well at 45 8C in ambient air. Partial sequencing analysis of the 16S rRNA gene of the isolates was performed using primer pair 8FPL (59-AGAGTTTGATC CTGGCTCAG-39) and 1492 (59-GGTTACCTTGTTACGAC TT-39) (Turenne et al., 2001) . The sequences were compared with published sequences in the GenBank database using the BLASTN algorithm. The closest matches were obtained with N. farcinica [GenBank accession no. AB162795, 99 . 9 % (1388/ 1390) identity] and N. otitidiscaviarum [GenBank accession no. X80611, 99 . 9 % (1388/1390) identity]. Negative xanthine and hypoxanthine hydrolysis reactions and the 16S rRNA sequencing findings confirmed the identification of the isolate as N. farcinica (Brown & McNeil, 2003) . MICs of the isolate were determined by the broth microdilution method and interpreted according to the guidelines provided by the National Committee for Clinical Laboratory Standards (2000). The isolate was resistant to ampicillin (MIC, .256 ìg ml À1 ), cefotaxime (.256 ìg ml À1 ) and gentamicin (64 ìg ml À1 ), and susceptible to amoxycillin/clavulanic acid (8 ìg ml À1 ), ciprofloxacin (0 . 25 ìg ml À1 ), amikacin (8 ìg ml À1 ) and trimethoprim/sulfamethoxazole (1 ìg ml À1 / 19 ìg ml À1 ).
The patient was treated with intravenous trimethoprim/ sulfamethoxazole alone. A follow-up chest radiograph 3 weeks after the start of treatment showed a gradual resolution of the nodular lesions. The patient was discharged on day 40 of hospitalization in good health with no detectable sequelae and a prescription of oral trimethoprim/sulfamethoxazole (160 mg/800 mg daily). A follow-up chest x-ray 2 months later showed complete resolution of the nodular lesions. During follow-up for 1 year, there was no evidence of recurrence.
Discussion
Nocardia species are ubiquitous soil-borne aerobic actinomycetes. Most reported human infections have been caused by Nocardia asteroides complex, Nocardia brasiliensis and, rarely, N. farcinica (Brown & McNeil, 2003) . N. farcinica, which was originally isolated by Nocard in 1888 from a case of bovine farcy, is the classical pathogen in bovine nocardiosis (Brown & McNeil, 2003) . Cases of human infection with N. farcinica are increasingly being diagnosed, because of the growing population of immunocompromised hosts and improved methods for detection and identification of Nocardia species in the clinical laboratory. N. farcinica was reported to constitute 19 % of 200 Nocardia isolates in a study from the USA (Wallace et al., 1990) , and 60 . 3 % of 131 isolates in a study from Germany (Peters et al., 1996) .
N. farcinica can cause a variety of clinical presentations including localized diseases and disseminated infections, especially in immunocompromised patients (Brown & McNeil, 2003; Boiron et al., 1992; Torres et al., 2000) . This organism is usually resistant to multiple antimicrobial agents, especially broad-spectrum cephalosporins, which might make treatment of the infection difficult (Brown & McNeil, 2003; Wallace et al., 1990) . Our patient presented with a disseminated infection (bacteraemia, multilobar pneumonia and brain abscesses) caused by N. farcinica, which was confirmed by the conventional identification method as well as 16S rRNA sequencing analysis (Wallace et al., 1990) . The lack of accurate identification of the isolate by the API CORNYE system made the use of an alternative method necessary, although this test may be the most widely ; years, 1966-2005) of the English-language literature identified 13 additional previously reported cases of N. farcinica bacteraemia (Farina et al., 1995; Farina et al., 2001; Torres et al., 2000; Ertl et al., 1987; Peters et al., 1996; Minamoto & Sordillo, 1998; Kontoyiannis et al., 1998; Bhave et al., 1999; Christidou et al., 2004; Hitti & Wolff, 2005) . Among the 14 cases (including the present case), there were 11 men and three women, with a mean age of 57 . 1 years. All patients had various underlying diseases (Table 1) . Lung involvement was present in eight patients, central nervous system disease in five and soft tissue involvement in three. Six patients died, two of whom had human immunodeficiency virus (HIV) infection and another two of whom were patients with malignancies. The overall mortality rate was 42 %, which is comparable to the 50 % mortality rate reported by Kontoyiannis et al. (1998) .
The portals of entry of N. farcinica are the respiratory tract and surgical or traumatic skin wounds (Beaman & Beaman, 1994; Boiron et al., 1992) . In our patient, we postulate that the organism might have gained access into the lung by aspiration or by haematogenous spread via a contaminated trivial cutaneous lesion at the farm visit. Because of the limited number of cases and often inadequate information on length of therapy, dose of antibiotics and drug sensitivity, the optimal treatment of N. farcinica bacteraemia remains unclear.
In conclusion, we report a case of disseminated infection due to N. farcinica in a uraemia patient with ITP receiving steroid therapy, which was successfully treated with trimethoprim/ sulfamethoxazole. Accurate identification of N. farcinica remains a challenge in clinical microbiology laboratories.
